PTC Therapeutics
PTCT
PTCT
197 hedge funds and large institutions have $2.44B invested in PTC Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 78 increasing their positions, 61 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less capital invested
Capital invested by funds: $2.48B → $2.44B (-$40M)
7.05% less ownership
Funds ownership: 111.13% → 104.08% (-7%)
11% less call options, than puts
Call options by funds: $5.76M | Put options by funds: $6.5M
Holders
197
Holding in Top 10
4
Calls
$5.76M
Puts
$6.5M
Top Buyers
| 1 | +$9.51M | |
| 2 | +$7.64M | |
| 3 | +$7.56M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.39M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$6.72M |
Top Sellers
| 1 | -$41.6M | |
| 2 | -$41.5M | |
| 3 | -$29.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$21.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$21M |